Definium director granted RSUs and stock options
Definium Therapeutics director Crystal Roger received new equity awards as part of her compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Definium Therapeutics director Crystal Roger received new equity awards as part of her compensation. She was granted 4,666 restricted stock units, each representing the right to receive one common share, and now holds 24,289 common shares after this award.
Roger was also granted a stock option covering 19,188 common shares at an exercise price of $24.11 per share, expiring on June 10, 2036. Both the RSUs and the option vest as to 1/12 of the underlying shares on each monthly anniversary of the grant date, with any remaining unvested portion vesting immediately before the company’s next annual meeting if it occurs within a year, subject to her continued service.
Insider Trade Summary
Grant/Award: 23,854 shares
Grant/Award
2 txns
Insider
CRYSTAL ROGER
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 19,188 | $0.00 | $0.00 |
| Grant/Award | Common Shares | 4,666 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 19,188 contracts (Direct);
Common Shares — 24,289 shares (Direct)
Footnotes (2)
- F1. These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, any unvested RSUs will vest immediately prior to the Issuer's annual meeting following the date of grant, subject the Reporting Person's continued service through the applicable vesting date.
- F2. The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, the Stock Option will vest and become exercisable immediately prior to the Issuer's annual meeting following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
RSUs granted: 4,666 units
Shares held after grant: 24,289 shares
Stock options granted: 19,188 options
+2 more
5 metrics
RSUs granted
4,666 units
Restricted stock units granted to director on June 11, 2026
Shares held after grant
24,289 shares
Common shares directly held by Crystal Roger after RSU award
Stock options granted
19,188 options
Stock option covering common shares granted on June 11, 2026
Option exercise price
$24.11 per share
Exercise price for 19,188-share stock option
Option expiration
June 10, 2036
Expiration date of granted stock option
Key Terms
restricted stock units ("RSUs"), Stock Option, vest, annual meeting
4 terms
restricted stock units ("RSUs") financial
"These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option financial
"The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"The RSUs vest as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting financial
"immediately prior to the Issuer's annual meeting following the date of grant"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Definium Therapeutics (DFTX) disclose for Crystal Roger?
Definium Therapeutics reported that director Crystal Roger received equity awards consisting of restricted stock units and a stock option. These compensation-related grants increase her equity stake and align her interests with common shareholders through future share ownership, subject to vesting conditions.
How many restricted stock units did Crystal Roger receive from Definium Therapeutics (DFTX)?
Crystal Roger received 4,666 restricted stock units from Definium Therapeutics. Each RSU represents a contingent right to receive one common share, subject to vesting. This award adds to her existing holdings and forms part of her overall director compensation package in equity.
What are the terms of Crystal Roger’s new stock option at Definium Therapeutics (DFTX)?
Crystal Roger received a stock option for 19,188 common shares with an exercise price of $24.11 per share, expiring June 10, 2036. The option vests in 12 equal monthly installments, with potential acceleration before the next annual meeting if conditions are met.
How do Crystal Roger’s RSUs at Definium Therapeutics (DFTX) vest?
Crystal Roger’s 4,666 RSUs vest in monthly installments, with 1/12 of the underlying shares vesting on each monthly anniversary of the grant. If the next annual meeting occurs within a year, any remaining unvested RSUs vest immediately before that meeting, subject to continued service.
Are Crystal Roger’s new equity awards at Definium Therapeutics (DFTX) routine compensation?
The Form 4 describes Crystal Roger’s transactions as grants or awards of RSUs and stock options, indicating compensation-related acquisitions rather than open-market trades. Such awards are commonly used to compensate directors and link their incentives to long-term shareholder value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates